Ancillary Symposium- Blazing Ahead with Advances in the Management of Adult Growth Hormone Disorder

Monday, June 15, 2020
Program: 12:00 – 1:30 pm 

This course is a virtual live CME-certified Ancillary Symposium to be presented at ENDO Online 2020. This educational activity is supported by an independent medical educational grant from Novo Nordisk Inc. These ancillary symposia are developed through the Endocrine Society’s Special Programs Committee (SPC).






Target Audience

This activity is intended for endocrinologists and endocrine fellows, primary care physicians, physician’s assistants, nurse practitioners and other healthcare professionals. 

Learning Objectives

Upon completion of this activity, participants should be able to:ble to: 

  • Identify aGHD based on presenting features and results of appropriate diagnostic tests 
  • Assess characteristics of current and emerging aGHD treatment options to identify optimal individualized regimens based on patients’ clinical and personal characteristics
  • Describe the available standard-of-care and emerging therapeutic approaches to address challenges of aGHD management, such as timely treatment initiation, treatment adherence, and therapeutic monitoring
  • Discuss disease management challenges associated with transitioning pediatric patients with GHD to adulthood

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Level of Outcomes: 
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 1.50 ABIM MOC
  • 1.50 AMA PRA Category 1 Credits
  • 1.50 CME Certificate of Participation
Course opens: 
Course expires: 


Mark E. Molitch, MD- Program Chair: 
Professor Emeritus
Northwestern University 
Chicago, IL
Julie Silverstein, MD
Medical Director Pituitary Center
Associate Professor of Medicine and Neurological Surgery
Division Endocrinology, Metabolism and Lipid Research
Washington University School of Medicine
St. Louis, MO
David R. Clemmons, MD
University of North Carolina
Chapel Hill, NC


The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. 

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable. 

The following faculty reported the following relevant financial relationships during the content development process for this activity:  
  • David R. Clemmons, MD: Advisory Board Member, Crinetics; Consulting, Novo Nordisk, Pfizer.
  • Mark E. Molitch, MD: Investigator, Novartis, Novo Nordisk, Chiasma; Consultant, Novartis, Novo Nordisk, Chiasma, Janssen, Sanofi, Corcept; Spouse and Daughter, Stock ownership of Amgen  
  • Julie Silverstein, MD: Research Investigator, Corcept Therapeutics, Chiasma, Strongbridge, Camurus, Ascendis

The Special Programs Committee reported no relevant financial relationship(s) during the content development process for this activity:                                                                                                                           

  • Neena Natt, MD
The following Special Programs Committee members reported financial relationships: 
  • Andjela T. Drincic, MD: Advisory Board Member, Corcept  
  • Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Esperion, AstraZeneca  
  •  Angela M. Leung, MD: Speaker,Medical Education Resources, MCE Conferences 
  • Amy Rothberg, MD: Advisor, Rhythm Pharmaceuticals; Spouse, consultant of Merck  

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.  

The following Special Programs Committee members reported no relevant financial relationships: 
  • Katherine Araque, MD; Jenny Blau, MD; Lorena Alarcon-Casas Wright, MD; Deborah Sellmeyer, MD, Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Click "Start" to complete the meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™ and 1.5 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions about content or obtaining CME credit, please contact the Endocrine Society at


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 


In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

  1. Provide your board-certification information in your educational profile.  Your profile currently contains the following board ID numbers (must be logged in to view):

    Your ABIM Number: *

    *If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.

  2. Update Profile

Available Credit

  • 1.50 ABIM MOC
  • 1.50 AMA PRA Category 1 Credits
  • 1.50 CME Certificate of Participation